Last reviewed · How we verify

Lidocaine 2% with 1:100 000 epinephrine

St. Joseph's Healthcare Hamilton · Phase 2 active Small molecule

Lidocaine 2% with 1:100 000 epinephrine is a Small molecule drug developed by St. Joseph's Healthcare Hamilton. It is currently in Phase 2 development. Also known as: Xylocaine.

At a glance

Generic nameLidocaine 2% with 1:100 000 epinephrine
Also known asXylocaine
SponsorSt. Joseph's Healthcare Hamilton
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Lidocaine 2% with 1:100 000 epinephrine

What is Lidocaine 2% with 1:100 000 epinephrine?

Lidocaine 2% with 1:100 000 epinephrine is a Small molecule drug developed by St. Joseph's Healthcare Hamilton.

Who makes Lidocaine 2% with 1:100 000 epinephrine?

Lidocaine 2% with 1:100 000 epinephrine is developed by St. Joseph's Healthcare Hamilton (see full St. Joseph's Healthcare Hamilton pipeline at /company/st-joseph-s-healthcare-hamilton).

Is Lidocaine 2% with 1:100 000 epinephrine also known as anything else?

Lidocaine 2% with 1:100 000 epinephrine is also known as Xylocaine.

What development phase is Lidocaine 2% with 1:100 000 epinephrine in?

Lidocaine 2% with 1:100 000 epinephrine is in Phase 2.

Related